FarmavitaR+

1. Understanding USP 71 Sterility Tests and Extended BUD
(QA and GMP/GMP/GLP/GCP/GDP)

One of the most frequently asked questions recently asks how to extend the Beyond-Use Date (BUD) of compounded sterile preparations (CSPs). Eric S. Kastango, RPh, MBA, FASHP, reviewed the requirements ...

2. Pharmaceutical Pricing & Reimbursement in Turkey
(Events/Events)

... initiatives and views. With a real intention to change the current situation and shape advanced processes: governmental bodies, the pharma industry and leading academics are strongly advocating initiatives ...

3. Advances in Imaging Biomarkers
(Reports/Market Report)

Innovative technologies, applications in R&D and clinical practice, and informatics and regulatory requirements This report discusses advances in key technologies, the use of imaging biomarkers ...

4. Pricing and Reimbursement Strategies
(Reports/Market Report)

Pricing and Reimbursement Strategies for Diagnostics: Overcoming reimbursement issues and navigating the regulatory environment The reimbursement for diagnostics is the key requirement for both the ...

5. Adaptive Clinical Trials
(Events/Events)

... of the design, and execution needed for adaptive clinical trials from companies paving the way within the industry. Learn how to conduct effective adaptive trials through specialized workshops for both ...

6. Clinical Trials 2010
(Events/Events)

Clinical Trials 2010 29th-30th September Frankfurt, Germany North West Business Group is proud to present the conference “Clinical Triasl 2010” in Frankfurt Germany. The Clinical Trials 2010 is ...

7. How to run the right clinical trials?
(Events/Events)

... Reveal, how to tailor clinical trials to the needs of the patients. Discuss the innovative methods of motivating patients and physicians. Learn from first hand experience, how to optimize patient recruitment ...

8. Ukraine in prospect of joining PIC/S
(Regulatory Affairs/Europe not-EU)

19-20 May 2010 in Geneva a meeting of the Executive Committee of the PIC / S was held. The Ukrainian delegation, headed by Alexei Soloviev, Chairman of the State Inspectorate for Quality Control of Drugs ...

9. Achieving preferential patient-access through innovative agreements with payers
(Events/Events)

2nd Annual Pharmaceutical Risk-Sharing & Value-Based Pricing & Reimbursement Models 14th-15th September, 2010 Washington DC, USA There is clearly an increasing need for more innovative pricing ...

10. Long-term pricing & reimbursement strategies to penetrate significant growth markets
(Events/Events)

2nd Annual Pharmaceutical Market & Patient Access for Chronic Disease Therapies 15th-16th September, 2010 Brussels, Belgium Chronic diseases are taking a steadily increasing share of national ...

11. Drug Repositioning & R&D Enhancement
(Events/Events)

3rd Annual Drug Repositioning & R&D Enhancement September 16-17, 2010 Philadelphia, PA, USA This conference will showcase more than 15 industry perspectives on the most effective scientific ...

12. Evolution Summit 2010
(Business News/Press Release)

  Overcoming International Obstacles in Clinical Trial Operations   Bernard Coulie, a speaker at the marcus evans Evolution Summit 2010 addresses the international barriers facing Chief Medical ...

13. Evolution Summit 2010
(Events/Events)

Evolution Summit 2010 27-29 October 2010, Fairmont Le Montreux Palace, Montreux, Switzerland The Evolution Summit 2010 offers the perfect setting for sponsors to present their products and services ...

14. eCTD
(Events/Events)

2nd Successful eCTD Lifecycle Management Prague, September 14th and 15th, 2010 Pharma IQ is delighted to announce the 2nd Successful eCTD Lifecycle Management conference, being held in Prague on ...

15. Fibromyalgia
(Regulatory Affairs/Regulatory Affairs News)

Fibromyalgia - Regulatory caution threatens EU market expansion Until regulatory hurdles in the EU are overcome, the US offers the greatest commercial potential and will be the primary growth market ...

16. Advertising of Reimbursed Drugs
(Pricing and Reimbursment/Pricing and Reimbursment)

Croatia - Agreement on Ethical Advertising of Reimbursed Drugs Due to the new Croatian Ordinance on pricing and reimbursement from this year , every MAH who wants to have its products on reimbursement ...

17. Counterfeit of medical products
(Regulatory Affairs/EMEA)

International Conference on counterfeit medical products paves the way to landmark convention aimed at protecting public health Basel (Switzerland), 16.04.2010 - More than 140 participants, senior ...

18. Pricing and Reimbursement Conference Review
(Pricing and Reimbursment/Pricing and Reimbursment)

Second annual Conference on Pharmaceutical Risk-Sharing  & Value-based Pricing and Reimbursement Models Bratislava, 15-16 th April 2010 Not being a specialist in the area of Risk-Sharing & ...

19. Introduction of Braille script for pharmaceuticals in Ukraine
(Regulatory Affairs/Europe not-EU)

20.05.2009 was introduced an amendment to the law of Ukraine “On medicines” (№ 124/96ВР of 4.04.96) which orders to use Braille script on packages. Changes came into force until 01.01.10. In Ukraine ...

20. Patern Ltd.
(Partners/Regulatory Affairs)

... of the pharmaceutical and health products, equipment and medical devices. Our history includes successful cooperation with companies all over the world: Germany, Austria, Italy, Spain, Poland, Hungary, ...